Şunu aradınız:: requirements for travel in arabia saudita (Danca - İtalyanca)

specific requirements for canines
specific requirements for canines

requirements for combined veterinary vaccines
requirements for combined veterinary vaccines

guidelines requirements for combined veterinary vaccines
vaccines dna vaccines non-amplifiable in

requirements for compatibility statements for veterinary vaccines
titolo del documento requirements for compatibility statements for veterinary vaccines

efficacy on anthelmintics: specific requirements for canine
efficacy on anthelmintics: specific requirements for canine

requirements for pharmaceutical documentation for pressurised metered dose inhalation products
ich q1f stability data package for registration in climatic zones iii and iv requirements for pharmaceutical documentation for pressurised metered dose inhalation products

note for guidance on requirements for pharmaceutical documentation for pressurised metered dose inhalation products
note for guidance on requirements for pharmaceutical documentation for pressurised metered dose inhalation products

"decommissioning requirements for ireland's demersal and shellfish fleets"
"decommissioning requirements for ireland's demersal and shellfish fleets"

harmonisation of requirements for equine influenza vaccines specific requirements for substitution or addition of a strain
harmonisation of requirements for equine influenza vaccines specific requirements for substitution or addition of a strain

mod et gebyr planter organisationen trees for travel træer, hver gang man har fløjet en tur.
per ogni passeggero che viaggia in aereo, dietro il pagamento di una certa somma, l' organizzazione trees for travel semina un albero.

points to consider on the requirements for clinical documentation for metered dose inhalers (mdi)
points to consider on the requirements for clinical documentation for metered dose inhalers (mdi)

testing of residual moisture eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies
testing of residual moisture eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies

titel på dokumentet antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
titolo del documento antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy

technical requirements for participation in target2-ecb regarding infrastructure , network and formats ( 1 ) target2 uses swift services for the exchange of messages .
technical requirements for participation in target2-ecb regarding infrastructure , network and formats ( 1 ) target2 uses swift services for the exchange of messages .

58 | reserveret unisig subset-097 | requirements for rbc-rbc safe communication interface | |
58 | riservato unisig subset-097 | requirements for rbc-rbc safe communication interface | |

hvis der anvendes aber i forbindelse med produktion af eller kvalitetskontrol med biologiske lægemidler, skal der tages særlig hensyn som fastsat i de gældende who requirements for biological substances, nr. 7.
nei casi in cui vengono usate le scimmie sono richieste precauzioni speciali, conformemente alle attuali disposizioni dell'oms per le sostanze biologiche (who requirements for biological substances no 7) .

stability testing of existing active substances and related finished products summary of requirements for active substances process validation (update) quality aspects of veterinary medicinal products administered via drinking water
stability testing of existing active substances and related finished products summary of requirements for active substances process validation (update) quality aspects of veterinary medicinal products administered via drinking water

note for guidance on cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines cpmp/ bwp/ 214/ 96
note for guidance on cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines cpmp/bwp/214/96

titel på dokumentet requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
titolo del documento requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:

concept paper on the revision of the cpmp/ bwp note for guidance (cpmp/ bwp/ 214/ 96) on harmonisation of requirements for influenza vaccines
concept paper on the revision of the cpmp/bwp note for guidance (cpmp/bwp/214/96) on harmonisation of requirements for influenza vaccines